(Q46705240)

24 December 2017

title

Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study (English)

1 reference

24 December 2017

author name string

Sandrine Rougier

1

1 reference

24 December 2017

Ioannis Vouldoukis

2

1 reference

24 December 2017

Sandrine Fournel

3

1 reference

24 December 2017

Sylvie Pérès

4

1 reference

24 December 2017

Frédérique Woehrlé

5

1 reference

24 December 2017

publication date

7 February 2008

1 reference

24 December 2017

published in

Veterinary Parasitology

1 reference

24 December 2017

volume

153

1 reference

24 December 2017

issue

3-4

1 reference

24 December 2017

page(s)

244-254

1 reference

24 December 2017

Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Immunomodulatory effects of quinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Newly documented antimicrobial activity of quinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Use of allopurinol for maintenance of remission in dogs with leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Pharmacokinetics of marbofloxacin in renal impairment in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Application of an in vivo culture system for rapid demonstration of anti-Leishmania activity of monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Treatment of canine Old World visceral leishmaniasis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Emergence of zoonotic canine leishmaniasis in the United States: isolation and immunohistochemical detection of Leishmania infantum from foxhounds from Virginia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Flow cytometric analysis of cellular immune responses in dogs experimentally infected with a North American isolate of Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Culture systems for production of promastigote and amastigote forms of Leishmania. Application to serological diagnosis and therapeutic trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2008.01.041

10.1016/J.VETPAR.2008.01.041

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18337012

1 reference

24 December 2017